Mesenchymal Stem Cells - Advances & Applications - Jsb Market Research

Mesenchymal Stem Cells - Advances & Applications

Released On 21st July 2015

This global strategic report is produced for:

*  Management of stem cell companies

* Management of regenerative therapy companies

*  Stem cell industry investors

 It is designed to increase your efficiency and effectiveness in:

 1. Commercializing mesenchymal stem cell (MSC) products, technologies, and therapies

 2. Making intelligent investment decisions

 3. Launching high-demand products

 4. Selling effectively to your client base

 5. Increasing revenue from MSC products and services

 6. Taking market share from your competition

 Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases.

 MSCs are advantageous over other stem cells types for a variety of reasons: they avoid the ethical issues that surround embryonic stem cell research, and repeated studies have found MSCs to be immuno-privileged, which make them an advantageous cell type for allogenic transplantation. MSCs reduce both the risks of rejection and complications of transplantation. Recently, there have been advances in the use of autologous mesenchymal stem cells to regenerate human tissues, including cartilage, meniscus, tendons, bone fractures, and more.

 This global strategic report explores recent advances in mesenchymal stem cells research applications, research priorities by market segment, and the competitive environment for Mesenchymal Stem Cells research products. It also identifies trend and growth patterns within the MSC industry. Because it is important for pharmaceutical companies interested to understand underlying forces...